1. Home
  2. NLSP vs BREA Comparison

NLSP vs BREA Comparison

Compare NLSP & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • BREA
  • Stock Information
  • Founded
  • NLSP 2015
  • BREA 2022
  • Country
  • NLSP Switzerland
  • BREA Ireland
  • Employees
  • NLSP N/A
  • BREA N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • NLSP Health Care
  • BREA Consumer Discretionary
  • Exchange
  • NLSP Nasdaq
  • BREA Nasdaq
  • Market Cap
  • NLSP 8.2M
  • BREA 9.9M
  • IPO Year
  • NLSP 2021
  • BREA 2023
  • Fundamental
  • Price
  • NLSP $0.19
  • BREA $0.70
  • Analyst Decision
  • NLSP Hold
  • BREA
  • Analyst Count
  • NLSP 1
  • BREA 0
  • Target Price
  • NLSP N/A
  • BREA N/A
  • AVG Volume (30 Days)
  • NLSP 11.0M
  • BREA 13.6K
  • Earning Date
  • NLSP 07-30-2024
  • BREA 07-23-2024
  • Dividend Yield
  • NLSP N/A
  • BREA N/A
  • EPS Growth
  • NLSP N/A
  • BREA N/A
  • EPS
  • NLSP N/A
  • BREA N/A
  • Revenue
  • NLSP N/A
  • BREA $120,788.00
  • Revenue This Year
  • NLSP N/A
  • BREA N/A
  • Revenue Next Year
  • NLSP N/A
  • BREA N/A
  • P/E Ratio
  • NLSP N/A
  • BREA N/A
  • Revenue Growth
  • NLSP N/A
  • BREA N/A
  • 52 Week Low
  • NLSP $0.11
  • BREA $0.53
  • 52 Week High
  • NLSP $1.21
  • BREA $3.00
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 49.01
  • BREA 36.05
  • Support Level
  • NLSP $0.19
  • BREA $0.61
  • Resistance Level
  • NLSP $0.24
  • BREA $0.72
  • Average True Range (ATR)
  • NLSP 0.03
  • BREA 0.07
  • MACD
  • NLSP -0.00
  • BREA 0.01
  • Stochastic Oscillator
  • NLSP 15.85
  • BREA 42.77

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a global portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: